Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions.
Industries BiotechnologyGeneticsHealth CareInformation TechnologyLife SciencePrecision MedicineHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Founded Date 2014 Founders Mickey Kertesz, Steve Quake, Tim Blauwkamp Operating Status Active Last Funding Type Series B Legal Name Karius, Inc. Hub Tags Emerging Unicorn
Company Type For Profit
Contact Email media@kariusdx.com Phone Number (866)452-7487
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious
disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.